Gar Y. Chan

Camperdown, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

A Confluence of Risk: An Aboriginal Man, Diabetes, and an SGLT2 Inhibitor.

A Confluence of Risk: An Aboriginal Man, Diabetes, and an SGLT2 Inhibitor.

Journal: The Permanente journal

Published: August 17, 2026

PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.

PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.

Journal: PloS one

Published: December 22, 2017

Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.

Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.

Journal: The AAPS journal

Published: February 29, 2016

Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.

Novel Inhaled Combination Powder Containing Amorphous Colistin and Crystalline Rifapentine with Enhanced Antimicrobial Activities against Planktonic Cells and Biofilm of Pseudomonas aeruginosa for Respiratory Infections.

Journal: Molecular pharmaceutics

Published: November 26, 2014

NanoXCT: a novel technique to probe the internal architecture of pharmaceutical particles.

NanoXCT: a novel technique to probe the internal architecture of pharmaceutical particles.

Journal: Pharmaceutical research

Published: March 10, 2014

Pulmonary drug delivery by powder aerosols.

Pulmonary drug delivery by powder aerosols.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 03, 2014

Emerging inhalation aerosol devices and strategies: where are we headed?

Emerging inhalation aerosol devices and strategies: where are we headed?

Journal: Advanced drug delivery reviews

Published: February 01, 2014

Advances in device and formulation technologies for pulmonary drug delivery.

Advances in device and formulation technologies for pulmonary drug delivery.

Journal: AAPS PharmSciTech

Published: January 14, 2014

An update on the use of rifapentine for tuberculosis therapy.

An update on the use of rifapentine for tuberculosis therapy.

Journal: Expert opinion on drug delivery

Published: January 09, 2014

A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.

A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.

Journal: Pharmaceutical research

Published: July 29, 2013

TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.

TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines.

Journal: Vaccine

Published: May 24, 2013

Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.

Aerosol delivery of nanoparticles in uniform mannitol carriers formulated by ultrasonic spray freeze drying.

Journal: Pharmaceutical research

Published: March 08, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026